TYK Medicines, Inc (HKG:2410)
Hong Kong · Delayed Price · Currency is HKD 6.67
-0.31 (-4.38%)
Aug 21, 2026, 4:08 PM HKT
TYK Medicines Market Cap
TYK Medicines has a market cap or net worth of 2.56 billion as of August 21, 2026. Its market cap has decreased by -55.97% in one year.
Market Cap
2.56B
Enterprise Value
2.50B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
6.67
ChartMarket Cap Chart
Since August 20, 2024, TYK Medicines's market cap has decreased from 5.08B to 2.56B, a decrease of -49.53%. That is a compound annual growth rate of -28.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 2.56B | -48.54% |
| Dec 31, 2025 | 4.98B | -71.50% |
| Dec 31, 2024 | 17.48B | 244.16% |
| Aug 20, 2024 | 5.08B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Recbio Technology | 3.08B |
| BioDlink International Company | 3.02B |
| Viva Biotech Holdings | 3.01B |
| Clover Biopharmaceuticals | 2.79B |
| HJ Science | 2.78B |
| Laekna | 2.66B |
| Shandong Boan Biotechnology | 2.60B |
| Beijing Luzhu Biotechnology | 2.59B |